Ovid Therapeutics (OVID) Non-cash Items (2016 - 2022)

Ovid Therapeutics has reported Non-cash Items for 7 years, with the latest figure at $3.1 million in Q1 2022.

• For the quarter ending Q1 2022, Non-cash Items fell 52.29% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2022 stood at $3.1 million (down 52.29% YoY), and the FY2021 full-year result was $2.4 million, up 266.3% from the prior year.
• Non-cash Items for Q1 2022 stood at $3.1 million, up from $2.4 million in the prior quarter.
• The five-year high for Non-cash Items was $18.2 million in Q2 2020, with the low at $142994.0 in Q2 2019.
• Historically, Non-cash Items has averaged $3.9 million across 5 years, with a median of $2.4 million in 2019.
• Annual changes were most pronounced in 2018 — Non-cash Items tumbled 98.12% — and 2020, when it jumped 12639.53%.
• Ovid Therapeutics' Non-cash Items stood at $153485.0 in 2018, then jumped by 2824.67% to $4.5 million in 2019, then slumped by 85.47% to $652438.0 in 2020, then jumped by 266.3% to $2.4 million in 2021, then increased by 28.84% to $3.1 million in 2022.
• The last three Non-cash Items figures came in at $3.1 million (Q1 2022), $2.4 million (Q4 2021), and $3.0 million (Q3 2021), per Business Quant data.